Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories

Page 2

Paragon passes acquisition exam
University of British Columbia spinout Paragon Testing Enterprises has agreed to an acquisition by Prometric Canada Testing Services.
Vaccitech shoots for US IPO
Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.
Dysonics takes a dive into Google
UC Davis spinout Dysonics was acquired by Google last year, it has emerged.
Coursera graduates to public markets in $519m IPO
The online learning platform developer spun out of Stanford University priced its shares at the top of their range.
Amgen rides to Rodeo acquisition
CWRU and UTMC-linked Rodeo Therapeutics is set to be acquired by Amgen for $55m in upfront and up to $666m in milestone payments.
Achilles ascends to Nasdaq
Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.
Lilium lands on $3.3bn reverse merger
The vertical take-off and landing jet developer, an Unternehmertum spinout, is joining forces with the Nasdaq-listed Qell Acquisition Corp.
Lava breaks through to public markets
Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.
Multiphoton Optics eyes exit
Heidelberg Instruments Mikrotechnik has acquired the Fraunhofer spinout for an undisclosed sum.
Akoya acts to file for $115m IPO
The tissue analysis device maker, a spinout from Stanford University, has selected the Nasdaq Global Select Market for its initial public offering.

test reg